Price $78.65 |
Market Cap
114.73B
|
Sector Health Care |
Div. Growth
50.20%
|
|
P/E
21.7
|
P/B
-
|
P/S
3.48
|
Dividend %
5.60%
|
|
P/CF
-
|
P/FCF
16.2
|
Op. Cash Flow
13.8M
|
FCF
4.7
|
|
Op. Margin
19.90%
|
Net Margin
16.30%
|
ROE
-94.50%
|
ROI
21.80%
|
|
ROA
8.70%
|
EPS Growth
-12.40%
|
Current Ratio
1.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| R1 RCM Inc (RCM) | $11.80 | - | - | 1.32B | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.39 | - | - | 56.6M | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $5.78 | - | - | 106.5M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $51.31 | - | - | 1.31B | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.70 | - | - | 44.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
